Search clinical trials for: Erlotinib Hydrocholoride
Total 884 results
-
University Health Network, TorontoOSI PharmaceuticalsCompleted
-
BayerCompletedCarcinoma, HepatocellularBelgium, France, Spain, Hong Kong, United States, Canada, Germany, Greece, New Zealand, Russian Federation, Australia, Taiwan, Austria, United Kingdom, China, Israel, Korea, Republic of, Bulgaria, Brazil, Poland, Italy, Colombia, South... and more
-
University of Southern CaliforniaOtsuka America PharmaceuticalCompleted
-
Hospices Civils de LyonCompletedStage IV Non-small Cell Lung CancerFrance
-
PfizerCompletedCarcinoma, Non Small Cell LungUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7United States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Clovis Oncology, Inc.TerminatedNon-Small Cell Lung CancerKorea, Republic of, United States, Spain, Hong Kong, Taiwan, Germany, Italy
-
Northwestern UniversityGenentech, Inc.; Amgen; OSI PharmaceuticalsCompleted
-
AHS Cancer Control AlbertaCross Cancer InstituteTerminatedNon-small Cell Lung Cancer | Advanced Solid MalignanciesCanada
-
The Netherlands Cancer InstituteDutch Society of Physicians for Pulmonology and TuberculosisTerminatedCarcinoma, Non-small Cell LungNetherlands
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Sun Yat-sen UniversityTerminatedNon-Small Cell Lung CarcinomaChina
-
M.D. Anderson Cancer CenterCompleted
-
Shanghai University of Traditional Chinese MedicineShanghai Chest Hospital; Shanghai Pulmonary Hospital, Shanghai, ChinaCompleted
-
Columbia UniversityGenentech, Inc.TerminatedProstate CancerUnited States
-
Oslo University HospitalTerminated
-
Oslo University HospitalThe Research Council of NorwayCompleted
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
SCRI Development Innovations, LLCNovartisCompletedNon Small Cell Lung CancerUnited States
-
University of BathCompletedExercise Metabolism Following Ethanol IngestionUnited Kingdom
-
Translational Oncology Research InternationalNational Cancer Institute (NCI)Completed
-
Daiichi Sankyo Co., Ltd.CompletedVenous ThromboembolismJapan, Taiwan
-
University Health Network, TorontoHoffmann-La RocheCompletedNasopharyngeal CancerCanada
-
Theodore LaetschTerminatedRelapsed / Recurrent Germ Cell TumorsUnited States
-
Geisinger ClinicGenentech, Inc.TerminatedHead and Neck CancerUnited States
-
Novartis PharmaceuticalsTerminatedCancerFrance, United States, Netherlands, Canada, Taiwan, Korea, Republic of
-
Astellas Pharma Global Development, Inc.Terminated
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Spain, Taiwan, China, United Kingdom, Denmark, Canada, Korea, Republic of, Germany, Italy, Netherlands, Singapore, Austria, France, Portugal, Greece, India, Mexico, Hungary, Turkey, Argentina, Chile, Ireland
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Eli Lilly and CompanyTerminatedRenal Cell Carcinoma | Metastases, Neoplasm | Neuroendocrine Tumors | Carcinoma, Non-small Cell LungFrance, United States
-
Sierra Oncology, Inc.TerminatedEGFR Mutated EGFR TKI Naive Metastatic NSCLCUnited States
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Memorial Sloan Kettering Cancer CenterIncyte CorporationCompleted
-
Eli Lilly and CompanyTerminated
-
Dartmouth-Hitchcock Medical CenterGenentech, Inc.; Ligand PharmaceuticalsCompletedCarcinoma, Non-small-cell LungUnited States
-
Konstantin DragnevGenentech, Inc.; Ligand PharmaceuticalsCompletedCarcinoma, Non-small-cell LungUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedHead and Neck CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States
-
Weill Medical College of Cornell UniversityOSI PharmaceuticalsCompletedCarcinoma, Non-small Cell LungUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
University of California, DavisNational Cancer Institute (NCI); Genentech, Inc.; Aventis PharmaceuticalsCompletedLung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
Zagazig UniversityCompletedDecompensated Cirrhosis
-
Emory UniversityNational Cancer Institute (NCI); Astellas Pharma Inc; Polyphenon PharmaCompletedCancer of Head and Neck | Neoplasms, Head and NeckUnited States
-
Cale JacobsVanderbilt UniversityCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedEGFR-Mutant Lung CancerUnited States
-
M.D. Anderson Cancer CenterAmgenCompletedSarcomaUnited States